ArticleBMC veterinary research2026
An organoid-based evaluation of Bacillus amyloliquefaciens SC06 in alleviating oxidative damage via Wnt signaling.
Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bacillus amyloliquefaciens SC06 (BaSC06) has emerged as a promising probiotic for improving animal gut health and immuno-protection. However, the underlying molecular mechanisms remain incompletely understood. In this study, we employed porcine intestinal organoids as an ex vivo model and induced oxidative stress using diquat to systematically evaluate the protective effects of BaSC06. We evaluated antioxidant capacity, apoptosis-related markers, intestinal stem cells differentiation markers, and associated signaling pathways. Pretreatment with BaSC06 significantly alleviated oxidative damage by reducing intracellular reactive oxygen species levels and resultant apoptosis. Cellularly, BaSC06 promoted intestinal stem cells proliferation and favored differentiation toward Paneth cells while suppressing differentiation into other epithelial lineages. Mechanistically, these effects were mediated by the activation of the Wnt signaling pathway, and it was further confirmed by using a specific Wnt inhibitor. Overall, our findings uncover a probiotic-Wnt axis through which BaSC06 confers protection against oxidative stress, involving modulation of intestinal stem cells fate and enhancement of epithelial barrier function.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.